Loading publications…
The last 5 uploaded publications
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Gautier Stoll, Stefano Ugel, Ilaria Marigo, Shin Foong Ngiow, Aurélien Marabelle, Armelle Prévost‐Blondel, Pierre-Olivier Gaudreau, Vancheswaran Gopalakrishnan, Alexander Eggermont, Paule Opolon, Christophe Klein, Gabriele Madonna, Paolo A. Ascierto, Antje Sucker, Dirk Schadendorf, Mark J. Smyth, Jean‐Charles Soria, Guido Guido Kroemer, Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel, Nicolas Jacquelot, Takahiro Yamazaki, María P. Roberti, Connie P.M. Duong, Miles C. Andrews, Loïc Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère, Meriem Messaoudene, David Enot (2019). Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. , 29(10), DOI: https://doi.org/10.1038/s41422-019-0224-x.
Article73 days agoThe oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
Takahiro Yamazaki, Jonathan M. Pitt, Marie Vétizou, Aurélien Marabelle, Chrystel Flores, Øystein Rekdal, Guido Guido Kroemer, Laurence Zitvogel (2016). The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade. , 23(6), DOI: https://doi.org/10.1038/cdd.2016.35.
Article73 days agoAnticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Dalil Hannani, Marie Vétizou, David Enot, Sylvie Rusakiewicz, Nathalie Chaput, David Klatzmann, Mélanie Desbois, Nicolas Jacquelot, Nadège Vimond, Salem Chouaı̈b, Christine Mateus, James P. Allison, Antoni Ribas, Jedd D. Wolchok, Jianda Yuan, Phillip Wong, Michael A. Postow, Andrzej Maćkiewicz, Jacek Mackiewicz, Dirk Schadendorff, Dirk Jaeger, Alan J. Korman, Keith S. Bahjat, Michele Maio, Luana Calabrò, Michele W.L. Teng, Mark J. Smyth, Alexander M.M. Eggermont, Caroline Robert, Guido Guido Kroemer, Laurence Zitvogel (2015). Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. , 25(2), DOI: https://doi.org/10.1038/cr.2015.3.
Article73 days agoCancer and the gut microbiota: An unexpected link
Laurence Zitvogel, Lorenzo Galluzzi, Sophie Viaud, Marie Vétizou, Romain Daillère, Miriam Mérad, Guido Guido Kroemer (2015). Cancer and the gut microbiota: An unexpected link. , 7(271), DOI: https://doi.org/10.1126/scitranslmed.3010473.
Article73 days agoResistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt, Marie Vétizou, Romain Daillère, María Paula Roberti, Takahiro Yamazaki, Bertrand Routy, Patricia Lepage, Ivo G. Boneca, Mathias Chamaillard, Guido Guido Kroemer, Laurence Zitvogel (2016). Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. , 44(6), DOI: https://doi.org/10.1016/j.immuni.2016.06.001.
Article73 days ago